ZVSA — ZYVERSA THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
ZVSA (ZYVERSA THERAPEUTICS INC) is tracked on HoldingsHub across five years of quarterly 13F filings. 25 funds have reported positions historically, with the sum of their latest reported stakes valued at $645.21K. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
Major shareholders of ZYVERSA THERAPEUTICS INC (ZVSA) include Goldman Sachs Group, Anson Funds Management LP, Walleye Capital LLC, ranked by reported 13F value among the 25 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q2 2025 | 6 | 66.07K | $44.73K | +25.7% |
| Q1 2025 | 7 | 69.88K | $43.92K | +45.6% |
| Q4 2024 | 8 | 81.08K | $86.17K | +158.6% |
| Q3 2024 | 5 | 3.01K | $7.22K | +264.2% |
| Q2 2024 | 4 | 10.30K | $38.75K | -91.8% |
| Q1 2024 | 7 | 84.96K | $62.84K | +130.1% |
| Q4 2023 | 6 | 201.59K | $181.44K | +20.4% |
| Q3 2023 | 12 | 1.20M | $157.28K | +0.3% |
Over the 8 quarters shown, institutional share counts decreased 94% in aggregate (Q3 2023 → Q2 2025); the largest single-quarter swing was Q3 2024 (+264.2%).
Top Institutional Holders (Q2 2025) — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 39.28K | $26.59K | 0.00% | Add | |
| 21.71K | $14.70K | 0.00% | Hold | |
| 4.53K | $3.06K | 0.00% | Add | |
| 274 | $186 | 0.00% | New | |
| 151 | $102 | 0.00% | Add | |
| 132 | $90 | 0.00% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q1 2025 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 28.33K | $17.82K | 0.00% | Add | |
| 21.71K | $13.64K | 0.00% | New | |
| 17.53K | $11.00K | 0.00% | Reduce | |
| 2.15K | $1.35K | 0.00% | Reduce | |
| 111 | $70 | 0.00% | Add | |
| 50 | $31 | 0.00% | Hold | |
| 1 | $1 | 0.00% | Hold |
Q4 2024 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 35.03K | $37.14K | 0.00% | New | |
| 25.26K | $27.00K | 0.00% | New | |
| 12.96K | $13.74K | 0.00% | New | |
| 4.19K | $4.44K | 0.00% | Add | |
| 3.48K | $3.69K | 0.00% | Add | |
| 109 | $115 | 0.00% | Add | |
| 50 | $53 | 0.00% | New | |
| 1 | $1 | 0.00% | Hold |
Q3 2024 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 2.57K | $6.16K | 0.00% | Add | |
| 433 | $1.04K | 0.00% | New | |
| 8 | $19 | 0.00% | Add | |
| 1 | $2 | 0.00% | Hold | |
| 1 | $2 | 0.00% | New |
Q2 2024 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.60K | $36.09K | 0.01% | New | |
| 699 | $2.63K | 0.00% | Reduce | |
| 7 | $26 | 0.00% | New | |
| 1 | $4 | 0.00% | Hold |
Q1 2024 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 31.20K | $23.40K | 0.00% | Add | |
| 19.91K | $14.93K | 0.00% | Add | |
| 12.12K | $9.09K | 0.00% | New | |
| 13.18K | $9.00K | 0.00% | New | |
| 8.54K | $6.41K | 0.00% | Add | |
| 11 | $9 | 0.00% | Add | |
| 1 | $1 | 0.00% | New |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| UBS Group AG | 39.28K | 28.33K | 4.19K | 433 | — | 19.91K | 3.27K | 107 | — | 3.28K | — |
| Geode Capital Management | 21.71K | 21.71K | — | — | — | — | — | 123.13K | — | — | — |
| Tower Research Capital LLC (TRC) | 4.53K | 2.15K | 3.48K | 2.57K | 699 | 8.54K | 3.98K | 5.77K | — | — | — |
| Citigroup Inc | 274 | — | 35.03K | — | — | — | — | — | — | — | — |
| SBI Securities Co., Ltd. | 151 | 50 | 50 | — | — | — | — | — | — | — | — |
| Bank of America Corp | 132 | 111 | 109 | 8 | 7 | — | — | 100 | 100 | — | — |
| Anson Funds Management LP | — | — | — | — | — | — | 160.67K | — | — | — | — |
| Walleye Capital LLC | — | — | — | — | — | — | — | 980.57K | — | — | — |
| ADAR1 Capital Management, LLC | — | — | — | — | 9.60K | — | — | — | — | — | — |
| Virtu Financial LLC | — | 17.53K | 25.26K | — | — | — | — | — | — | — | — |
| TWO SIGMA SECURITIES, LLC | — | — | — | — | — | 31.20K | 18.67K | — | — | — | — |
| Renaissance Technologies | — | — | 12.96K | — | — | — | — | — | — | — | — |
| Citadel Advisors | — | — | — | — | — | — | 14.99K | — | — | — | — |
| JANE STREET GROUP, LLC | — | — | — | — | — | 12.12K | — | — | — | — | — |
| HRT FINANCIAL LP | — | — | — | — | — | 13.18K | — | — | — | — | — |
| Vanguard Group | — | — | — | — | — | — | — | 17.19K | 17.19K | 16.89K | — |
| XTX Topco Ltd | — | — | — | — | — | — | — | 16.71K | — | — | — |
| MILLENNIUM MANAGEMENT LLC | — | — | — | — | — | — | — | 15.19K | — | — | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | — | — | — | — | — | — | — | 13.54K | — | — | — |
| Winthrop Advisory Group LLC | — | — | — | — | — | — | — | 13.36K | — | — | — |
FAQ
Which funds hold ZVSA?
25 funds have reported positions in ZVSA across five years of 13F filings; the sum of their latest reported stakes is $645.21K.
Who are the top institutional holders of ZVSA?
The largest 13F holders are Goldman Sachs Group, Anson Funds Management LP, Walleye Capital LLC, ADAR1 Capital Management, LLC, UBS Group AG; the top 25 are ranked at the top of this page.
Who are the major shareholders of ZYVERSA THERAPEUTICS INC?
The major shareholders of ZYVERSA THERAPEUTICS INC (ZVSA) by reported 13F value are Goldman Sachs Group, Anson Funds Management LP, Walleye Capital LLC, ADAR1 Capital Management, LLC, UBS Group AG, among 25 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.